Medications
acalabrutinib
Tyrosine Kinase Inhibitors
Approved use in
B-Cell Prolymphocytic Leukemia
alemtuzumab
Monoclonal Antibodies
Approved use in
B-Cell Prolymphocytic Leukemia
cladribine
Chemotherapy Agents
Approved use in
B-Cell Prolymphocytic Leukemia
doxorubicin
Chemotherapy Agents
Approved use in
B-Cell Prolymphocytic Leukemia
epirubicin
Chemotherapy Agents
Approved use in
B-Cell Prolymphocytic Leukemia
ibrutinib
Tyrosine Kinase Inhibitors
Approved use in
B-Cell Prolymphocytic Leukemia
idelalisib
Targeted Therapies
Approved use in
B-Cell Prolymphocytic Leukemia
mitoxantrone
Chemotherapy Agents
Approved use in
B-Cell Prolymphocytic Leukemia
obinutuzumab
Monoclonal Antibodies
Approved use in
B-Cell Prolymphocytic Leukemia
ofatumumab
Monoclonal Antibodies
Approved use in
B-Cell Prolymphocytic Leukemia
pentostatin
Chemotherapy Agents
Approved use in
B-Cell Prolymphocytic Leukemia
rituximab
Monoclonal Antibodies
Approved use in
B-Cell Prolymphocytic Leukemia
venetoclax
Targeted Therapies
Approved use in
B-Cell Prolymphocytic Leukemia